The new guidelines, published in the Journal of the American Academy of Dermatology (JAAD), will guide dermatologists in deciding the best possible prevention and treatment options for pediatric ...

Please provide your email address to receive an email when new articles are posted on . Children were 59% more likely to have atopic dermatitis if their mothers had atopic dermatitis. Similar patterns ...

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.

Results of the study revealed that 45.2% of the parents of children with parent-reported atopic dermatitis (AD) did not fulfill the AASM sleep recommendations vs 37.1% of the parents of children ...

Antibiotics administered within the first year of life for any reason were associated with a near doubling of risk of atopic dermatitis. Greater antibiotic exposure was associated with greater AD risk ...

Also called eczema, atopic dermatitis is estimated to affect 10 to 20 percent of children, usually babies or very young kids, although it can last past adolescence and into adulthood. The skin ...

Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children whether ...

Atopic dermatitis (AD) during childhood is not associated with increases in markers of cardiovascular risk, according to a study published online March 24 in JAMA Network Open.

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a ...

In this video, Kristin Sokol, MD, MPH, FAAAAI, FACAAI, discusses the impact of atopic dermatitis on patients' quality of life.

A population-based UK cohort study found that children and adolescents with atopic dermatitis (AD), even those with more severe or persistent disease, did not show increased markers ...